Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1998
11/03/1998US5830858 Neurotrophic factor
11/03/1998US5830852 Compositions for insulin-receptor mediated nucleic acid delivery
11/03/1998US5830849 Vampire bat salivary plasminogen activators
11/03/1998US5830847 Soluble TGF-β-binding endoglin polypeptides and homodimers
11/03/1998US5830770 Immunoassay of pesticides
11/03/1998US5830758 Binding to lymphocytes
11/03/1998US5830755 T-cell receptors and their use in therapeutic and diagnostic methods
11/03/1998US5830754 Recombinant DNA-produced T11 and fragments thereof
11/03/1998US5830747 Plant arabinogalactan protein (AGP) genes
11/03/1998US5830742 TNF-α converting enzyme
11/03/1998US5830721 Libraries of peptides, antibodies
11/03/1998US5830710 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
11/03/1998US5830709 Detection method for homologous portions of a class of substances
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830703 DNA encoding adrenomedullin
11/03/1998US5830698 Kit with unique site for recombination of bacterial, insect, viral and synthetic dna
11/03/1998US5830684 Production of native or recombinant guanine triphosphatase-activating protein
11/03/1998US5830681 Cardiovascular disorders
11/03/1998US5830677 Colon adenocarcinoma-associated proteins detected rapidly and reproducibly at early stages of disease
11/03/1998US5830676 Mutated colorectal cancer protein allows highly specific assays to be performed to assess the neoplastic status of a particular tissue or predisposition to cancer
11/03/1998US5830675 Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis
11/03/1998US5830670 Definitive diagnostic test
11/03/1998US5830667 Human P450 IID6 cytochrome-derived peptide fragments, anti-peptide fragment antibodies, applications thereof in the diagnosis of autoimmune hepatitis
11/03/1998US5830663 Human heavy and light chain variable domains, genes rescued from popultions of cells by ?in-cell? pcr
11/03/1998US5830660 Tumorigenesis protein
11/03/1998US5830650 Walk-through mutagenesis
11/03/1998US5830646 Diagnostic method
11/03/1998US5830636 HEV orf-2 monoclonal antibodies and methods for using same
11/03/1998US5830634 Aids diagnosis, screening blood doners
11/03/1998US5830478 Method for delivering functional domains of diphtheria toxin to a cellular target
11/03/1998US5830476 Active induction or passive immunization of anti-Gp48 antibodies and isolated gp48 protein
11/03/1998US5830473 Antibodies against T cells as therapeutics
11/03/1998US5830472 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
11/03/1998US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998US5830470 Humanized antibodies to ganglioside GM2
11/03/1998US5830469 Novel monoclonal antibodies that specifically bind to the extracellular domain of human fas antigen (aka: apo-1) for the treatment of diseases related to excess unwanted programmed or activation-induced cell death.
11/03/1998US5830448 Compositions and methods for the treatment of tumors
11/03/1998CA1340110C Carcinoma-associated antigens, and antibodies which recognize these antigens
11/03/1998CA1340109C Immunoassay for hiv-1 antigens using f(ab')2 fragments as probe
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998WO1998048051A2 Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof
10/29/1998WO1998048022A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
10/29/1998WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998048010A1 Novel human tumour suppressor gene
10/29/1998WO1998048008A1 Methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules
10/29/1998WO1998048001A1 Methods for differentiating neural stem cells
10/29/1998WO1998047923A1 Il-5r antagonists for treatment of inflammation, asthma and other allergic diseases
10/29/1998WO1998047922A2 Determination of recombinant glycosylated proteins and peptides in biological fluids
10/29/1998WO1998047917A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
10/29/1998WO1998047915A1 Neoglycoproteins
10/29/1998WO1998047531A2 Fc receptor non-binding anti-cd3 monoclonal antibodies deliver a partial tcr signal and induce clonal anergy
10/29/1998WO1998047525A1 MATERIALS AND METHODS RELATING TO INHIBITING THE INTERACTION OF p53 AND mdm2
10/29/1998WO1998047480A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
10/29/1998WO1998047343A2 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998WO1998027999A3 Anti-allergenic compounds for the treatment of immune diseases containing haptenized antigen antibody complexes
10/29/1998WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998DE19748688A1 Membransystem zur gesteuerten Geweberegeneration bei Erkrankungen des Zahnhalteapparates Membrane system for guided tissue regeneration in diseases of the gums
10/29/1998DE19717656A1 DNA-Sequenzen kodierend für die Untereinheit CHLD pflanzlicher Magnesium-Chelatasen, sowie Verfahren zur Aktivitätsbestimmung pflanzlicher Magnesium-Chelatasen DNA sequences encoding the subunit CHLD vegetable magnesium chelatases, as well as procedures for determining activity of vegetable magnesium chelatases
10/29/1998CA2288227A1 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
10/29/1998CA2287590A1 Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof
10/29/1998CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998CA2287438A1 Novel human tumour suppressor gene
10/29/1998CA2287344A1 Materials and methods relating to inhibiting the interaction of p53 and mdm2
10/29/1998CA2286865A1 Edg-1-like receptor
10/29/1998CA2284729A1 Neoglycoproteins
10/29/1998CA2283755A1 Human complement c3-degrading proteinase from streptococcus pneumoniae
10/28/1998EP0874053A2 3-Dehydroquinate synthase (aroB)
10/28/1998EP0874052A2 Nucleic acid encoding a human protein phosphatase
10/28/1998EP0874051A2 OSP a protein of borrelia burgdorferi subgroups, encoding genes and vaccines.
10/28/1998EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998EP0874049A1 Nucleic acid sequences of CIITA genes
10/28/1998EP0874048A2 Human hedgehog protein
10/28/1998EP0873999A1 Antibody to the prorenin profragment, renin-active substance containing the same and prorenin assay reagent using the same
10/28/1998EP0873755A1 Prevention and treatment of enterohemorrhagic E. coli infection
10/28/1998EP0873521A1 Method for potentiating tissue plasminogen activators
10/28/1998EP0873408A1 Calcium binding proteolipid compositions and methods
10/28/1998EP0873407A1 Apo-2 ligand
10/28/1998EP0873363A1 Novel high affinity human antibodies to tumor antigens
10/28/1998EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA
10/28/1998EP0873354A1 Novel amp activated protein kinase
10/28/1998EP0873353A1 IgG SEPARATION MEDIUM AND NOVEL PROTEIN A VARIANT
10/28/1998EP0873349A1 Endothelial-monocyte activating polypeptide iii
10/28/1998EP0873140A2 Immunoconjugate for the treatment of aids
10/28/1998EP0873138A2 Improved pharmaceutical compositions
10/28/1998EP0873136A2 High fluorescence specific immune enhancing factor and methods of use for same
10/28/1998EP0873135A1 Peanut allergens and methods
10/28/1998EP0873132A1 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO
10/28/1998EP0598717B1 Duplex printer
10/28/1998EP0587719B1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO)
10/28/1998EP0407392B2 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES